Li Zhengya, Zeng Yuxiao, Chen Xi, Li Qiyou, Wu Wei, Xue Langyue, Xu Haiwei, Yin Zheng Qin
Southwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.
Southwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.
Cytotherapy. 2016 Jun;18(6):771-84. doi: 10.1016/j.jcyt.2016.03.001. Epub 2016 Apr 8.
Retinal degeneration (RD) is an inherited eye disease characterized by irreversible photoreceptor loss. Conventionally, the activation of the resident microglia is secondary to the disease. Stem cell-based therapy has recently made rapid progress in treating RD. Although it has been demonstrated that the effect of stem cell therapy may include immunomodulation, the specific mechanisms have not been clarified.
Immunocytochemistry, terminal deoxynucleotidyl transferase UTP nick end labelling (TUNEL) assay and Western blot were used to analyze the microglia activation and photoreceptor apoptosis in the retina of rd1 mice. GFP-C17.2 neural stem cells (NSCs) were transplanted into the subretinal space to study the immunomodulatory and neuroprotective effects. The transwell co-culture of BV2 cells with GFP-C17.2 was performed to study the proliferation, apoptosis and secretion levels of inflammatory factors. Real time-quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) were performed to explore the gene and protein level of factors secreted by NSCs and microglia.
TUNEL-positive cells were primarily distributed in the inner nuclear layer (INL) of rd1 mice on P8d, appeared in the outer nuclear layer (ONL) on P10d and peaked on P14d. Meanwhile, microglia migrated to the ONL and reached the maximum level, accompanied by the changes in the levels of fractalkine and its unique receptor CX3CR1 protein. After transplantation of NSCs on P7d into the subretinal space of rd1 mice, the activated microglia were inhibited and the degeneration of ONL was delayed. In addition, microglia activation was suppressed by co-cultured NSCs in vitro. The gene and protein level of tissue inhibitor of metalloproteinase (TIMP1) in NSCs was elevated, whereas that of matrix metalloproteinase (MMP9) in BV2 microglia was markedly suppressed in this co-culture system.
Transplanted NSCs in the retina exerted immunomodulatory effects on microglia, thus delaying the degeneration of photoreceptors.
视网膜变性(RD)是一种以不可逆的光感受器丧失为特征的遗传性眼病。传统上,视网膜常驻小胶质细胞的激活是该疾病的继发结果。基于干细胞的治疗方法最近在治疗RD方面取得了快速进展。尽管已经证明干细胞治疗的效果可能包括免疫调节,但具体机制尚未阐明。
采用免疫细胞化学、末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)和蛋白质免疫印迹法分析rd1小鼠视网膜中小胶质细胞的激活和光感受器凋亡情况。将绿色荧光蛋白标记的C17.2神经干细胞(NSCs)移植到视网膜下间隙,以研究其免疫调节和神经保护作用。通过BV2细胞与绿色荧光蛋白标记的C17.2细胞的Transwell共培养,研究炎症因子的增殖、凋亡及分泌水平。采用实时定量聚合酶链反应(RT-qPCR)和酶联免疫吸附测定(ELISA)法,探讨神经干细胞和小胶质细胞分泌因子的基因和蛋白水平。
TUNEL阳性细胞在出生后第8天主要分布于rd1小鼠的内核层(INL),出生后第10天出现在外核层(ONL),并在出生后第14天达到峰值。与此同时,小胶质细胞迁移至ONL并达到最高水平,伴随趋化因子及其独特受体CX3CR1蛋白水平的变化。在出生后第7天将神经干细胞移植到rd1小鼠的视网膜下间隙后,激活的小胶质细胞受到抑制,ONL的退变延迟。此外,体外共培养的神经干细胞可抑制小胶质细胞的激活。在该共培养系统中,神经干细胞中金属蛋白酶组织抑制剂(TIMP1)的基因和蛋白水平升高,而BV2小胶质细胞中基质金属蛋白酶(MMP9)的基因和蛋白水平则明显受到抑制。
视网膜中移植的神经干细胞对小胶质细胞具有免疫调节作用,从而延缓光感受器的退变。